Edwards Lifesciences (EW) News Today $71.29 -0.06 (-0.08%) Closing price 03/25/2025 03:58 PM EasternExtended Trading$71.45 +0.16 (+0.22%) As of 03/25/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Edwards Lifesciences Corp. stock rises Monday, still underperforms marketMarch 25 at 9:02 PM | marketwatch.comVanguard Group Inc. Raises Holdings in Edwards Lifesciences Co. (NYSE:EW)Vanguard Group Inc. raised its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 69,132,036 shares of the medical research companyMarch 25 at 5:44 AM | marketbeat.comKLP Kapitalforvaltning AS Purchases Shares of 222,022 Edwards Lifesciences Co. (NYSE:EW)KLP Kapitalforvaltning AS purchased a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 222,022 shares of the medical research compaMarch 25 at 5:19 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by American Century Companies Inc.American Century Companies Inc. lowered its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 37.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,166,057 shares of the medical research company's stock after selling 684,027 sharMarch 25 at 4:39 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Given Consensus Rating of "Hold" by BrokeragesEdwards Lifesciences Co. (NYSE:EW - Get Free Report) has earned an average recommendation of "Hold" from the twenty-six analysts that are currently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, thirteen have issued a hold recommeMarch 25 at 2:24 AM | marketbeat.com80,758 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Simplify Asset Management Inc.Simplify Asset Management Inc. bought a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 80,758 shares of the medical research company'sMarch 24 at 6:18 AM | marketbeat.comMizuho Securities USA LLC Buys 16,838 Shares of Edwards Lifesciences Co. (NYSE:EW)Mizuho Securities USA LLC boosted its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 43.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,900 shares of the medical research company's stoMarch 24 at 4:59 AM | marketbeat.comCommonwealth of Pennsylvania Public School Empls Retrmt SYS Reduces Stake in Edwards Lifesciences Co. (NYSE:EW)Commonwealth of Pennsylvania Public School Empls Retrmt SYS lowered its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 125,409 sharesMarch 23 at 5:06 AM | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Acquired by Royal London Asset Management Ltd.Royal London Asset Management Ltd. lifted its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 251,205 shares of the medical research company's stock after pMarch 23 at 4:56 AM | marketbeat.comEdwards Lifesciences: Double-Digit Top Line And EPS Growth AheadMarch 23 at 12:09 AM | seekingalpha.comEdwards Lifesciences: Double-Digit Top Line And EPS Growth AheadMarch 23 at 12:02 AM | seekingalpha.comSector Gamma AS Lowers Position in Edwards Lifesciences Co. (NYSE:EW)Sector Gamma AS lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 99,000 shares of the medical research company's stMarch 22, 2025 | marketbeat.com75,308 Shares in Edwards Lifesciences Co. (NYSE:EW) Acquired by Northwest & Ethical Investments L.P.Northwest & Ethical Investments L.P. acquired a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 75,308 shares of the medical researchMarch 22, 2025 | marketbeat.comCorient Private Wealth LLC Has $6.96 Million Position in Edwards Lifesciences Co. (NYSE:EW)Corient Private Wealth LLC decreased its position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 12.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 94,066 shares of the medical research cMarch 22, 2025 | marketbeat.comEnvestnet Portfolio Solutions Inc. Has $2.50 Million Position in Edwards Lifesciences Co. (NYSE:EW)Envestnet Portfolio Solutions Inc. lowered its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 10.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 33,828 shares oMarch 22, 2025 | marketbeat.comPiper Sandler Sticks to Their Hold Rating for Edwards Lifesciences (EW)March 21, 2025 | markets.businessinsider.comTrillium Asset Management LLC Sells 9,333 Shares of Edwards Lifesciences Co. (NYSE:EW)Trillium Asset Management LLC cut its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 9.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 94,694 shares of the medical research company's stock after selMarch 21, 2025 | marketbeat.comGenerali Asset Management SPA SGR Invests $2.35 Million in Edwards Lifesciences Co. (NYSE:EW)Generali Asset Management SPA SGR purchased a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 31,741 shares of the medical research company's stock, valued at approximMarch 21, 2025 | marketbeat.comEdwards Lifesciences’ Growth Potential Boosted by Favorable NCD and Strategic InitiativesMarch 20, 2025 | tipranks.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Investment House LLCInvestment House LLC lowered its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 3.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 161,574 shares of the medical research company's stock after selling 6,280 shares during tMarch 20, 2025 | marketbeat.comThrivent Financial for Lutherans Cuts Position in Edwards Lifesciences Co. (NYSE:EW)Thrivent Financial for Lutherans decreased its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,158,750 shares of the medical research company's stock after sellingMarch 20, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Stake Lessened by Intech Investment Management LLCIntech Investment Management LLC lessened its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 57.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 170,395 shares of the medical research company'sMarch 19, 2025 | marketbeat.comMirova US LLC Has $133.94 Million Holdings in Edwards Lifesciences Co. (NYSE:EW)Mirova US LLC reduced its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,809,222 shares of the medical research company's stockMarch 19, 2025 | marketbeat.comPrimecap Management Co. CA Grows Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Primecap Management Co. CA lifted its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 14.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,043,500 shares of the medical research company'sMarch 19, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Purchased by Cibc World Markets CorpCibc World Markets Corp grew its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 14.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 93,645 shares of the medicalMarch 19, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Commonwealth Equity Services LLCCommonwealth Equity Services LLC decreased its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 15.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 163,558 shares of the medical research compaMarch 19, 2025 | marketbeat.comIndependent Advisor Alliance Invests $374,000 in Edwards Lifesciences Co. (NYSE:EW)Independent Advisor Alliance purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,047 shares oMarch 19, 2025 | marketbeat.comTerra Alpha Investments LLC Invests $1.60 Million in Edwards Lifesciences Co. (NYSE:EW)Terra Alpha Investments LLC purchased a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 21,580 shares of the medical reMarch 18, 2025 | marketbeat.comHaven Capital Group Inc. Purchases Shares of 52,279 Edwards Lifesciences Co. (NYSE:EW)Haven Capital Group Inc. purchased a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 52,279 shares of the medical research compMarch 18, 2025 | marketbeat.comNatixis Advisors LLC Grows Stock Position in Edwards Lifesciences Co. (NYSE:EW)Natixis Advisors LLC raised its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 51.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 288,443 shares of the medical research company's stock after buying an additional 98,554 shares duMarch 18, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Sees Significant Decline in Short InterestEdwards Lifesciences Co. (NYSE:EW - Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 28th, there was short interest totalling 8,490,000 shares, a decline of 28.7% from the February 13th total of 11,900,000 shares. Based on an average daily volume of 4,740,000 shares, the short-interest ratio is presently 1.8 days. Currently, 1.5% of the company's shares are short sold.March 17, 2025 | marketbeat.comGlenview Trust co Sells 57,982 Shares of Edwards Lifesciences Co. (NYSE:EW)Glenview Trust co lowered its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 14.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 357,562 shares of the medical research compMarch 17, 2025 | marketbeat.comPatten & Patten Inc. TN Has $11.41 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW)Patten & Patten Inc. TN lowered its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 154,180 shares of the medical research company's stock afMarch 17, 2025 | marketbeat.comChoate Investment Advisors Sells 20,624 Shares of Edwards Lifesciences Co. (NYSE:EW)Choate Investment Advisors lessened its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 13.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 129,357 shares of the medical research compMarch 17, 2025 | marketbeat.comGWN Securities Inc. Purchases New Position in Edwards Lifesciences Co. (NYSE:EW)GWN Securities Inc. purchased a new stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund purchased 9,525 shares of the medical research company's stock, valued at approximately $658,000. Several otMarch 17, 2025 | marketbeat.comAchmea Investment Management B.V. Sells 7,778 Shares of Edwards Lifesciences Co. (NYSE:EW)Achmea Investment Management B.V. lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 42,612 shares of the medical reseaMarch 16, 2025 | marketbeat.comVestcor Inc Raises Holdings in Edwards Lifesciences Co. (NYSE:EW)Vestcor Inc grew its stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 44.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 15,793 shares of the medical research company's stock after buying an additional 4,887 shares during the quarter. Vestcor Inc'March 16, 2025 | marketbeat.comProficio Capital Partners LLC Purchases New Position in Edwards Lifesciences Co. (NYSE:EW)Proficio Capital Partners LLC purchased a new stake in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor purchased 114,228 shares of the medical research company's stock, valued at approximately $8,456,March 16, 2025 | marketbeat.comPostrock Partners LLC Acquires Shares of 5,128 Edwards Lifesciences Co. (NYSE:EW)Postrock Partners LLC bought a new position in Edwards Lifesciences Co. (NYSE:EW - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 5,128 shares of the medical research company's stock, valued at approximately $380,000. Several othMarch 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Stock Holdings Lowered by Wellington Shields Capital Management LLCWellington Shields Capital Management LLC cut its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 63,732 shares of the medical research compaMarch 15, 2025 | marketbeat.comSwiss National Bank Sells 86,800 Shares of Edwards Lifesciences Co. (NYSE:EW)Swiss National Bank decreased its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 4.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,701,800 shares of the medical research cMarch 15, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) VP Sells $645,620.00 in StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Donald E. Bobo, Jr. sold 9,500 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $67.96, for a total value of $645,620.00. Following the completion of the sale, the vice president now directly owns 46,936 shares of the company's stock, valued at approximately $3,189,770.56. This trade represents a 16.83 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 14, 2025 | marketbeat.comInsider Selling: Edwards Lifesciences Co. (NYSE:EW) VP Sells 9,500 Shares of StockMarch 14, 2025 | insidertrades.comSkandinaviska Enskilda Banken AB publ Grows Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Skandinaviska Enskilda Banken AB publ boosted its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 6.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 949,074 shares of the medical research company's sMarch 14, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Raises Stock Position in Edwards Lifesciences Co. (NYSE:EW)Connor Clark & Lunn Investment Management Ltd. raised its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 77.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 380,103 shares of the medical research company's stock aftMarch 13, 2025 | marketbeat.comEdwards Lifesciences Co. (NYSE:EW) Shares Sold by Victory Capital Management Inc.Victory Capital Management Inc. cut its holdings in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) by 2.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 217,525 shares of the medical research company's stocMarch 13, 2025 | marketbeat.comWilson Asset Management International PTY Ltd. Sells 207,798 Shares of Edwards Lifesciences Co. (NYSE:EW)Wilson Asset Management International PTY Ltd. trimmed its position in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 60.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 138,793 shares of the medical research company's stock after selling 207,7March 12, 2025 | marketbeat.comNatural Investments LLC Makes New $392,000 Investment in Edwards Lifesciences Co. (NYSE:EW)Natural Investments LLC acquired a new position in shares of Edwards Lifesciences Co. (NYSE:EW - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 5,303 shares of the medical research company's stock, valued at apMarch 12, 2025 | marketbeat.comDaiwa Securities Group Inc. Boosts Stock Holdings in Edwards Lifesciences Co. (NYSE:EW)Daiwa Securities Group Inc. grew its holdings in Edwards Lifesciences Co. (NYSE:EW - Free Report) by 7.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 96,971 shares of the medical research company's stocMarch 12, 2025 | marketbeat.comDaniel J. Lippis Sells 400 Shares of Edwards Lifesciences Co. (NYSE:EW) StockEdwards Lifesciences Co. (NYSE:EW - Get Free Report) VP Daniel J. Lippis sold 400 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $69.48, for a total value of $27,792.00. Following the transaction, the vice president now owns 22,588 shares of the company's stock, valued at $1,569,414.24. This trade represents a 1.74 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 11, 2025 | marketbeat.com Remove Ads Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address EW Media Mentions By Week EW Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EW News Sentiment▼1.510.79▲Average Medical News Sentiment EW News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EW Articles This Week▼2722▲EW Articles Average Week Remove Ads Get Edwards Lifesciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EW and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Boston Scientific News Stryker News Medtronic News Becton, Dickinson and Company News IDEXX Laboratories News ResMed News DexCom News STERIS News Insulet News Baxter International News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:EW) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryBryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edwards Lifesciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edwards Lifesciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
